Owlet, Inc. reported second quarter 2026 financial results on August 11, 2026, achieving record revenue of $33.9 million, a 29.9% increase from the prior year period. Subscription revenue reached $3.2 million, up $2.4 million year-over-year. The company reported a net loss of $0.6 million, significantly improved from a $37.4 million loss in Q2 2025, largely due to a one-time tariff refund impact. Adjusted EBITDA was $6.7 million, compared to $0.5 million in the prior year period. Management updated its full-year 2026 revenue guidance to $118–$122 million and raised adjusted EBITDA expectations to $10.75–$12.75 million, reflecting the tariff refund benefit. The company also announced revisions to previously issued financial statements for periods ending March 31, 2026, and annual periods in 2024 and 2025 to correct stock-based compensation valuation errors related to its employee stock purchase plan. Owlet operates in the pediatric health technology sector, providing FDA-cleared wearable infant monitors and subscription-based monitoring services.

Owlet, Inc. and its subsidiary Owlet Baby Care, Inc. entered into a $25,000,000 asset-based revolving credit facility with Wells Fargo Bank, National Association, effective June 26, 2026. The company used an initial draw of $17,063,000 to refinance and extinguish existing debt from ABL OPCO LLC and WTI Fund X, Inc. The facility matures on its third anniversary and includes financial covenants regarding liquidity and EBITDA thresholds. Owlet, Inc. develops and manufactures smart baby monitoring technology.